| Charles Scott Needham, MD | |
|
2805 Valencia Dr, Idaho Falls, ID 83404-7597 | |
| (208) 525-9400 | |
| (208) 535-4569 |
| Full Name | Charles Scott Needham |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 33 Years |
| Location | 2805 Valencia Dr, Idaho Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063435899 | NPI | - | NPPES |
| 122226100 | Other | WY | MDCD PIN |
| 000092896 | Other | MT | BCBS PIN |
| 0151589 | Other | MT | MDCD PIN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Southern Utah | St george, UT | Home health agency |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Provas Of Salt Lake Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407410244 PECOS PAC ID: 1850620303 Enrollment ID: O20190909001007 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Provas Of Ogden, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073170031 PECOS PAC ID: 2769815117 Enrollment ID: O20191126000546 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Advanced Vein And Vascular Of Salt Lake City Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386272755 PECOS PAC ID: 8325460173 Enrollment ID: O20200624000454 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Advanced Vein And Vascular Of Southern Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326679952 PECOS PAC ID: 9335563394 Enrollment ID: O20200723000473 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Advanced Vein And Vascular Of Utah Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093329427 PECOS PAC ID: 6406276765 Enrollment ID: O20201026003049 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Advanced Vein And Vascular Of Northern Utah, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700490133 PECOS PAC ID: 0244640670 Enrollment ID: O20210326000629 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | Hillside Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083209589 PECOS PAC ID: 4688074842 Enrollment ID: O20210610001060 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Entity Name | St George Heart And Vascular |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831815984 PECOS PAC ID: 8224400536 Enrollment ID: O20230215001249 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Scott Needham, MD 2805 Valencia Dr, Idaho Falls, ID 83404-7597 Ph: (208) 525-9400 | Charles Scott Needham, MD 2805 Valencia Dr, Idaho Falls, ID 83404-7597 Ph: (208) 525-9400 |
News Archive
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.
› Verified 9 days ago
Edward R Setser, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste A205, Idaho Falls, ID 83404 Phone: 208-535-4580 Fax: 208-535-4520 | |
Dr. Michael H Denyer, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2225 Teton Plz, Ste B, Idaho Falls, ID 83404 Phone: 208-524-4660 Fax: 208-524-4617 | |
Dr. Denis P Raleigh, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 3200 Channing Way Ste 205, Idaho Falls, ID 83404 Phone: 208-535-4580 | |
David Lyle Joyce, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 205, Idaho Falls, ID 83404 Phone: 208-535-4580 |